PT  - JOURNAL ARTICLE
AU  - Chatterjee, Usha
AU  - Butina, Michelle
TI  - Biomarkers of Infection and Inflammation
AID  - 10.29074/ascls.119.001891
DP  - 2020 Jan 01
TA  - American Society for Clinical Laboratory Science
PG  - ascls.119.001891
4099  - http://hwmaint.clsjournal.ascls.org/content/early/2020/01/20/ascls.119.001891.short
4100  - http://hwmaint.clsjournal.ascls.org/content/early/2020/01/20/ascls.119.001891.full
AB  - Biomarkers, or biological markers, have been tested in the clinical laboratory for decades. More recently, there has been a surge in research studies aimed at identifying biomarkers of infection and inflammation. One of the foremost motivators in this expansion of research is the quest to find ideal biomarkers for sepsis. Traditional, yet still relevant, laboratory markers of infection and inflammation consist of the white blood cell count, erythrocyte sedimentation rate, and C-reactive protein. Newer biomarkers that are currently available in the clinical laboratory and used for the evaluation of sepsis include lactate and procalcitonin, while two promising emergent biomarkers for the evaluation of sepsis, pentraxin 3 and presepsin, are presented. Beyond sepsis, promising emergent biomarkers for chronic wound infections, pneumonia, and invasive fungal infections are also discussed.